Bioinformatic prediction of CTL and Th mixed epitopes of GPIIb/IIIa antibody
Li Zhang-qiu,Hu Hai-yan,Liu Shun-hui,Zhang Mei-xia,Lu Zhi-gang
2009-01-01
Abstract:Background: GPIIb/IIIa is common platelet glycoprotein in idiopathic thrombocytopenic purpura (ITP) patients. It has been demonstrated that after the idiotype antibody of GPIIb/GPIIIa binding platelet activating complement, platelet destruction occurred in ITP patients. Objective: Using bioinformatics approach to human platelet glycoprotein antibodies (GPIIb/IIIa) to target its CTL, Th cell epitopes in multi-parameter forecast. Design, Time and Setting: Open trial was performed at the laboratory of Department of Hematology, Zhujiang Hospital from May to August 2008. Materials: Amino acid sequence of GPIIb/IIIa antibody was provided by Genbank. Methods: HLA-A*0201, HLA-A*1101, and HLA-A*2401 CTL restricted epitopes of platelet membrane glycoprotein IIb/IIIa antibody of human and mice were predicted by SYFPEITHI, RANKPEP, BIMAS, SVMHC, PREDEP, MHCPRED and PROPRED predictive programs. In the results, the peptides found in HLAPRED that can lead to autoimmune disease and has been published were removed, and the epitopes of HLA-A*0201 must cover the epitopes of HLA-A*1101 and HLA-A*2401, combined to predTAP and TAPPred for predicting binding affinity of peptides toward the TAP transporter and NetChop, MAPPP, PAProc for predicting cleavages; HLA-DR Th restricted epitopes of GPIIb/IIIa antibody were predicted by SYFPEITHI, RANKPEP, MHCPRED and HLAPRED. After removing the peptides found in HLAPRED, the Th epitopes must cover the CTL mixed epitopes above, and the final epitopes were the CTL, Th mixed epitopes. Results: Five peptides of CTL, Th mixed epitopes of GPIIb/GPIIIa antibody of human were selected from more than 1 740 peptides. They were located at the aa1-15, aa24-38, aa50-64, aa65-81, and aa109-121 of GPIIb/ IIIa antibody-human and 5 peptides of CTL and Th mixed epitopes of GPIIb/ GPIIIa antibody of mice were located at the aa1-15, aa26-40, aa46-60, aa68-82, and aa93-107 of GPIIb/IIIa antibody-mice. Conclusion: The mixed CTL and Th restricted epitopes of platelet membrane glycoprotein IIb/III antibody can be used to prepare specific antibody, and also can become new target for the new vaccine development of ITP.